1. Scientific factors for assessing biosimilarity and drug interchangeability of follow-on biologics;Chow;Biosimilars,2011
2. EMEA Note for Guidance on the Investigation of Bioavailability and Bioequivalence. The European Medicines Agency Evaluation of Medicines for Human Use 2001
3. EMEA Note for Guidance on Comparability of Medicinal Products Containing Biotechnology-derived Proteins as Drug Substance - Non Clinical and Clinical Issues. The European Medicines Agency Evaluation of Medicines for Human Use 2003
4. EMEA Rev. 1 Guideline on Comparability of Medicinal Products Containing Biotechnology-derived Proteins as Drug Substance - Quality Issues. The European Medicines Agency Evaluation of Medicines for Human Use 2003
5. EMEA Guideline on Similar Biological Medicinal Products. The European Medicines Agency Evaluation of Medicines for Human Use 2005